Anda Biopharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Investors
  • 9

Anda Biopharma General Information

Description

Developer of personalized cancer treatments designed for tumor neoantigen management. The company's technology integrates artificial intelligence, single-cell sequencing, organoid chips and digital twin analysis, enabling healthcare providers to deliver personalized vaccines for cancer and tumor patients.

Contact Information

Formerly Known As
Anda Biology Medicine Developement (Shenzhen), Anda Biopharmaceutical Development (Shenzhen)
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 303-443, 3rd Floor, Building 4, Number 9, Yike Road
  • Life Science Park, Changping District
  • Beijing, 100000
  • China
+86 188
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Corporate Office
  • Room 303-443, 3rd Floor, Building 4, Number 9, Yike Road
  • Life Science Park, Changping District
  • Beijing, 100000
  • China
+86 188

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anda Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A1) 23-Aug-2026 Completed Generating Revenue
4. Secondary Transaction - Private 01-Jul-2026 Completed Generating Revenue
3. Later Stage VC 23-Mar-2025 Completed Generating Revenue
2. Early Stage VC 20-Jan-2021 Completed Generating Revenue
1. Seed Round 01-Feb-2019 Completed Startup
To view Anda Biopharma’s complete valuation and funding history, request access »

Anda Biopharma Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Chang Development Corporation Minority
Feixi County Industrial Park Investment Holding (Group) Venture Capital Minority
Hongtai Capital Holdings Venture Capital Minority
DFJ DragonFund China Venture Capital Minority
Leading Capital Company Asset Manager Minority
You’re viewing 5 of 9 investors. Get the full list »

Anda Biopharma FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process